Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.96
0.10 (0.59%)
At close: Aug 15, 2025, 2:44 PM
Seres Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MCRB stock have an median target of 15, with a low estimate of 6 and a high estimate of 200. The median target predicts a decrease of -11.56% from the current stock price of 16.96.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 6 | 73.67 | 15 | 200 |
| Change | -64.62% | 334.38% | -11.56% | 1079.25% |
Latest Analyst Insight Report
Chardan Capital has downgraded Seres Therapeutics ... Unlock content with Pro Subscription
Updated May 08, 2025
| Rating | Sep 24 | Oct 24 | Nov 24 | Mar 25 | May 25 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 0 | 2 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 1 | 0 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
5.88M
from 0
Increased by n/a%
Revenue Next Year
25M
from 5.88M
Increased by 325.5%
EPS This Year
-0.37
from 0
Increased by n/a%
EPS Next Year
-10.18
from -0.37
Increased by -2.65K%